Tom Lund
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 1
- CAR-T cell therapy research 1
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Laura Gómez-Cuadrado (1 shared paper)Marta Canel (1 shared paper)Robert J. B. Nibbs (1 shared paper)Adam Byron (1 shared paper)Jennifer E. Ring (1 shared paper)Alex von Kriegsheim (1 shared paper)Andrew H. Sims (1 shared paper)Stephen M. Anderton (1 shared paper)
- Journals
- Cancer Cell (1 paper)The Journal of Pathology (1 paper)Nature Cancer (1 paper)Cancer Discovery (1 paper)Nature Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Tom Lund
13 papers receiving 1.6k citations
Tom Lund's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 805
- Immunology 542
- Cancer Research 344
- Immunology and Allergy 115
- Pulmonary and Respiratory Medicine 305
Countries citing papers authored by Tom Lund
This map shows the geographic impact of Tom Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Lund more than expected).
Fields of papers citing papers by Tom Lund
This network shows the impact of papers produced by Tom Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Lund. The network helps show where Tom Lund may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Lund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoantigen-directed immune escape in lung cancer evolution Hit paper breakdown → | 2019 | 722 |
| 2 | 2015 | 340 | |
| 3 | 2020 | 212 | |
| 4 | 2021 | 187 | |
| 5 | 2020 | 73 | |
| 6 | 2020 | 63 | |
| 7 | 2006 | 34 | |
| 8 | 2023 | 10 | |
| 9 | 2024 | 8 | |
| 10 | 2007 | 5 | |
| 11 | 2025 | 4 | |
| 12 | 2025 | 3 | |
| 13 | 2018 | 2 | |
| 14 | Designing a new generation of anti-hCG vaccines for cancer therapy | 2006 | 0 |
About Tom Lund
Tom Lund is a scholar working on Oncology, Immunology, Cancer Research, Immunology and Allergy and Aerospace Engineering, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (5 papers), Cancer Genomics and Diagnostics (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Animal Virus Infections Studies (1 paper), Cell Adhesion Molecules Research (1 paper), CAR-T cell therapy research (1 paper) and Space Exploration and Technology (1 paper). The work is most often cited by research in Oncology (805 citations), Immunology (542 citations), Cancer Research (344 citations), Immunology and Allergy (115 citations) and Pulmonary and Respiratory Medicine (305 citations). Tom Lund has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Laura Gómez-Cuadrado, Marta Canel, Robert J. B. Nibbs, Adam Byron, Jennifer E. Ring, Alex von Kriegsheim, Andrew H. Sims, Stephen M. Anderton, Eleni Maniati and Nick Gilbert. Their work appears in journals such as Cancer Cell, The Journal of Pathology, Nature Cancer, Cancer Discovery and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.